Finally, new hope for solid tumor patients comes from a compound that probably represents the first idea of a small molecule cancer cell inhibitor since it targets one of the most common, and even for years considered undruggable, mutated protein in cancers, KRAS G12C. This evidence concerns the gene KRAS and cancer.